Home526139 • BOM
add
Transgene Biotek Ltd
Nakaraang pagsara
₹6.97
Sakop ng araw
₹6.63 - ₹7.29
Sakop ng taon
₹5.79 - ₹12.46
Market cap
481.26M INR
Average na Volume
30.02K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Mga balita tungkol sa merkado
MarketWatch
1 araw ang nakalipas
Wall Street sees ‘no alternative’ to U.S. stocks in 2025. Here’s why.
0.072%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.02M | 127.33% |
Gastos sa pagpapatakbo | 1.58M | -16.19% |
Net na kita | -734.00K | 44.64% |
Net profit margin | -71.75 | 75.65% |
Kita sa bawat share | — | — |
EBITDA | -328.50K | -103.00% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 113.00K | 7.54% |
Kabuuang asset | 1.42B | -0.21% |
Kabuuang sagutin | 1.31B | -0.03% |
Kabuuang equity | 108.32M | — |
Natitirang share | 75.77M | — |
Presyo para makapag-book | 4.87 | — |
Return on assets | — | — |
Return on capital | -0.57% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -734.00K | 44.64% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Itinatag
1990
Website
